Meet the new Allenex in Stockholm, May 15 at 3 pm

The new Allenex, as a pure transplantation company, is presenting at Avanza Bank stock market day.

Now that our new Allenex in its new role as a pure transplantation company has reported its first quarterly operating profit, I greet old and new shareholders welcome to see and hear my presentation of our new Allenex. We sell our leading and new products on a growing market. Welcome to Avanza Bank stock market day at Operaterassen in Stockholm, Tuesday May 15. I will present Allenex at 3 pm. There is also an opportunity to ask questions after the presentation”

Sincerely
Anders Karlsson, CEO.

For more information and registration, go to  www.financialhearings.com  

For additional information, please contact:
Anders Karlsson, CEO, tel: +46-70-91 800 10, e-mail:
anders.karlsson@allenex.se
Yvonne Axelsson, CFO, tel: +46-8-508 939 72 e-mail:
yvonne.axelsson@allenex.se

Allenex is a life science-company that develop, manufacture, market and sell products for safer transplants of organs and bone marrow on the global market. Allenex is listed on NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 54 persons are employed in the Allenex group.

About Us

LinkMed, in collaboration with innovators, develops new life science companies. By contributing entrepreneurship and capital, LinkMed has created a portfolio of eleven companies, six in biotechnology and five in medical technology. The LinkMed share is listed on the OMX Nordic Exchange Stockholm in the small-cap sector (ticker:LMED). The company’s largest owners are FastPartner, Koncentra Holding, and the founder Ingemar Lagerlöf. See www.linkmed.se for more information.

Subscribe

Documents & Links